vs

Side-by-side financial comparison of Evommune, Inc. (EVMN) and High Roller Technologies, Inc. (ROLR). Click either name above to swap in a different company.

Evommune, Inc. is the larger business by last-quarter revenue ($10.0M vs $6.3M, roughly 1.6× High Roller Technologies, Inc.). High Roller Technologies, Inc. runs the higher net margin — 58.4% vs -124.8%, a 183.1% gap on every dollar of revenue. High Roller Technologies, Inc. produced more free cash flow last quarter ($-90.0K vs $-59.9M).

Evommune, Inc. is a clinical-stage biotechnology company focused on developing innovative therapies for chronic inflammatory and immunological diseases. Its pipeline includes novel candidates targeting unmet medical needs for conditions such as atopic dermatitis, psoriasis, and other immune-mediated disorders, primarily serving global healthcare markets.

S&S – Sansei Technologies is an American company known for its pneumatically powered amusement rides and roller coaster designing.

EVMN vs ROLR — Head-to-Head

Bigger by revenue
EVMN
EVMN
1.6× larger
EVMN
$10.0M
$6.3M
ROLR
Higher net margin
ROLR
ROLR
183.1% more per $
ROLR
58.4%
-124.8%
EVMN
More free cash flow
ROLR
ROLR
$59.8M more FCF
ROLR
$-90.0K
$-59.9M
EVMN

Income Statement — Q3 FY2025 vs Q3 FY2025

Metric
EVMN
EVMN
ROLR
ROLR
Revenue
$10.0M
$6.3M
Net Profit
$-12.5M
$3.7M
Gross Margin
Operating Margin
-133.3%
1.3%
Net Margin
-124.8%
58.4%
Revenue YoY
-16.4%
Net Profit YoY
831.9%
EPS (diluted)
$-8.07
$0.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EVMN
EVMN
ROLR
ROLR
Q3 25
$10.0M
$6.3M
Q2 25
$6.9M
Q1 25
$6.8M
Q3 24
$7.5M
Net Profit
EVMN
EVMN
ROLR
ROLR
Q3 25
$-12.5M
$3.7M
Q2 25
$-592.0K
Q1 25
$-3.3M
Q3 24
$-501.0K
Operating Margin
EVMN
EVMN
ROLR
ROLR
Q3 25
-133.3%
1.3%
Q2 25
-7.2%
Q1 25
-47.4%
Q3 24
-6.3%
Net Margin
EVMN
EVMN
ROLR
ROLR
Q3 25
-124.8%
58.4%
Q2 25
-8.5%
Q1 25
-48.4%
Q3 24
-6.7%
EPS (diluted)
EVMN
EVMN
ROLR
ROLR
Q3 25
$-8.07
$0.39
Q2 25
$-0.07
Q1 25
$-0.39
Q3 24
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EVMN
EVMN
ROLR
ROLR
Cash + ST InvestmentsLiquidity on hand
$76.1M
$2.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$-183.1M
$6.6M
Total Assets
$84.5M
$16.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EVMN
EVMN
ROLR
ROLR
Q3 25
$76.1M
$2.7M
Q2 25
$2.7M
Q1 25
$3.5M
Q3 24
$1.3M
Stockholders' Equity
EVMN
EVMN
ROLR
ROLR
Q3 25
$-183.1M
$6.6M
Q2 25
$2.6M
Q1 25
$2.8M
Q3 24
$-779.0K
Total Assets
EVMN
EVMN
ROLR
ROLR
Q3 25
$84.5M
$16.0M
Q2 25
$12.3M
Q1 25
$12.8M
Q3 24
$12.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EVMN
EVMN
ROLR
ROLR
Operating Cash FlowLast quarter
$-59.7M
$-78.0K
Free Cash FlowOCF − Capex
$-59.9M
$-90.0K
FCF MarginFCF / Revenue
-598.7%
-1.4%
Capex IntensityCapex / Revenue
1.3%
0.2%
Cash ConversionOCF / Net Profit
-0.02×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EVMN
EVMN
ROLR
ROLR
Q3 25
$-59.7M
$-78.0K
Q2 25
$-840.0K
Q1 25
$-3.6M
Q3 24
Free Cash Flow
EVMN
EVMN
ROLR
ROLR
Q3 25
$-59.9M
$-90.0K
Q2 25
$-845.0K
Q1 25
$-3.6M
Q3 24
FCF Margin
EVMN
EVMN
ROLR
ROLR
Q3 25
-598.7%
-1.4%
Q2 25
-12.2%
Q1 25
-53.5%
Q3 24
Capex Intensity
EVMN
EVMN
ROLR
ROLR
Q3 25
1.3%
0.2%
Q2 25
0.1%
Q1 25
0.2%
Q3 24
Cash Conversion
EVMN
EVMN
ROLR
ROLR
Q3 25
-0.02×
Q2 25
Q1 25
Q3 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EVMN
EVMN

Segment breakdown not available.

ROLR
ROLR

Net Gaming Revenue$4.9M77%
Net Revenue Noncore Services$1.4M23%

Related Comparisons